HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thyroglobulin in carcinoma of the thyroid: an immunohistochemical study.

Abstract
To determine the value of thyroglobulin as an immunohistochemical marker for thyroid neoplasms, we studied 42 primary thyroid carcinomas, 38 metastatic carcinomas, and four sarcomas involving the thyroid gland. All follicular and papillary carcinomas, regardless of their morphologic variation, stained positively for thyroglobulin, whereas the medullary carcinomas, metastatic tumors, and sarcomas showed negative staining reactions. The only small-cell variant of follicular carcinoma and ten of 14 spindle and giant cell carcinomas showed the lowest thyroglobulin reactivity. It is concluded that immunohistochemical demonstration of thyroglobulin is a sensitive and specific method of identifying thyroid carcinomas of follicular cell origin.
AuthorsJ Albores-Saavedra, M Nadji, F Civantos, A R Morales
JournalHuman pathology (Hum Pathol) Vol. 14 Issue 1 Pg. 62-6 (Jan 1983) ISSN: 0046-8177 [Print] United States
PMID6832751 (Publication Type: Journal Article)
Chemical References
  • Thyroglobulin
Topics
  • Carcinoma (immunology, secondary)
  • Carcinoma, Papillary (immunology)
  • Histocytochemistry
  • Humans
  • Immunochemistry
  • Lung Neoplasms (secondary)
  • Sarcoma (immunology)
  • Thyroglobulin (immunology)
  • Thyroid Neoplasms (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: